{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:26:02Z","timestamp":1792463162373,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40121-026-01380-x","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:17:13Z","timestamp":1781342233000},"page":"2121-2143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Clinical and Symptomatic Burden Among Older Adults with Respiratory Syncytial Virus: A Real-World Survey in Five European Countries"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1672-4906","authenticated-orcid":false,"given":"Diana","family":"Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9093-0134","authenticated-orcid":false,"given":"James","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3473-151X","authenticated-orcid":false,"given":"Emily","family":"Quinones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0435-0422","authenticated-orcid":false,"given":"Mayesha","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1039-9620","authenticated-orcid":false,"given":"Libby","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8013-2399","authenticated-orcid":false,"given":"St\u00e9phane","family":"Fi\u00e9vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Di Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra L\u00f3pez-Ib\u00e1\u00f1ez","family":"de Aldecoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-1021","authenticated-orcid":false,"given":"James","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2785-7103","authenticated-orcid":false,"given":"Reiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"1380_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11111324","author":"B Busack","year":"2022","unstructured":"Busack B, Shorr AF. Going viral-RSV as the neglected adult respiratory virus. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11111324.","journal-title":"Pathogens"},{"issue":"4","key":"1380_CR2","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s40121-023-00792-3","volume":"12","author":"Y Li","year":"2023","unstructured":"Li Y, Kulkarni D, Begier E, Wahi-Singh P, Wahi-Singh B, Gessner B, et al. Adjusting for case under-ascertainment in estimating RSV hospitalisation burden of older adults in high-income countries: a systematic review and modelling study. Infect Dis Ther. 2023;12(4):1137\u201349.","journal-title":"Infect Dis Ther."},{"key":"1380_CR3","doi-asserted-by":"crossref","unstructured":"Nguyen-Van-Tam JS, O'Leary M, Martin ET, Heijnen E, Callendret B, Fleischhackl R, et al. Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. Eur Respir Rev. 2022;31(166).","DOI":"10.1183\/16000617.0105-2022"},{"issue":"1","key":"1380_CR4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/13696998.2024.2389676","volume":"27","author":"B Huebbe","year":"2024","unstructured":"Huebbe B, Mocek A, Manz KC, Vivirito A, Bayer LJ, Norris R, et al. Economic burden of respiratory syncytial virus in adults in Germany - a health claims analysis between 2015 and 2018. J Med Econ. 2024;27(1):1063\u201375.","journal-title":"J Med Econ."},{"issue":"12","key":"1380_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70181","volume":"19","author":"K Horn Emily","year":"2025","unstructured":"Horn Emily K, Singer D, Booth A, Nguyen H, Saiontz-Martinez C, Berger A. Prevalence and age at diagnosis of risk factors for severe respiratory syncytial virus disease among US adults: an analysis of 2011\u20132020 NHANES data. Influenza Other Respir Viruses. 2025;19(12):e70181.","journal-title":"Influenza Other Respir Viruses."},{"issue":"4","key":"1380_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1183\/09031936.00059814","volume":"44","author":"MJ Divo","year":"2014","unstructured":"Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44(4):1055\u201368.","journal-title":"Eur Respir J."},{"issue":"6","key":"1380_CR7","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/cid\/ciab595","volume":"74","author":"AR Branche","year":"2022","unstructured":"Branche AR, Saiman L, Walsh EE, Falsey AR, Sieling WD, Greendyke W, et al. Incidence of respiratory syncytial virus infection among hospitalized adults, 2017\u20132020. Clin Infect Dis. 2022;74(6):1004\u201311.","journal-title":"Clin Infect Dis."},{"issue":"2","key":"1380_CR8","first-page":"98","volume":"12","author":"EE Walsh","year":"2012","unstructured":"Walsh EE, Falsey AR. Respiratory syncytial virus infection in adult populations. Infect Dis. 2012;12(2):98\u2013102.","journal-title":"Infect Dis."},{"key":"1380_CR9","doi-asserted-by":"crossref","unstructured":"Franczuk P, Tkaczyszyn M, Kulak M, Domenico E, Ponikowski P, Jankowska EA. Cardiovascular complications of viral respiratory infections and COVID-19. Biomedicines. 2022;11(1).","DOI":"10.3390\/biomedicines11010071"},{"issue":"14","key":"1380_CR10","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.jacc.2018.02.013","volume":"71","author":"KS Ivey","year":"2018","unstructured":"Ivey KS, Edwards KM, Talbot HK. Respiratory syncytial virus and associations with cardiovascular disease in adults. J Am Coll Cardiol. 2018;71(14):1574\u201383.","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"1380_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70097","volume":"19","author":"C Liang","year":"2025","unstructured":"Liang C, Polkowska-Kramek A, Lade C, Bayer LJ, Bruyndonckx R, Huebbe B, et al. Estimated incidence rate of specific types of cardiovascular and respiratory hospitalizations attributable to respiratory syncytial virus among adults in Germany between 2015 and 2019. Influenza Other Respir Viruses. 2025;19(5):e70097.","journal-title":"Influenza Other Respir Viruses."},{"issue":"3","key":"1380_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/irv.12929","volume":"16","author":"D Curran","year":"2022","unstructured":"Curran D, Cabrera ES, Bracke B, Raymond K, Foster A, Umanzor C, et al. Impact of respiratory syncytial virus disease on quality of life in adults aged \u226550 years: a qualitative patient experience cross-sectional study. Influenza Other Respir Viruses. 2022;16(3):462\u201373.","journal-title":"Influenza Other Respir Viruses."},{"issue":"1","key":"1380_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/irv.12903","volume":"16","author":"AR Falsey","year":"2022","unstructured":"Falsey AR, Walsh EE, Osborne RH, Vandendijck Y, Ren X, Witek J, et al. Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post-discharge assessed by Respiratory Intensity and Impact Questionnaire. Influenza Other Respir Viruses. 2022;16(1):79\u201389.","journal-title":"Influenza Other Respir Viruses."},{"issue":"1","key":"1380_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50634","volume":"6","author":"YJ Juhn","year":"2023","unstructured":"Juhn YJ, Wi CI, Takahashi PY, Ryu E, King KS, Hickman JA, et al. Incidence of respiratory syncytial virus infection in older adults before and during the COVID-19 pandemic. JAMA Netw Open. 2023;6(1):e2250634.","journal-title":"JAMA Netw Open."},{"issue":"16","key":"1380_CR15","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1016\/j.vaccine.2023.03.024","volume":"41","author":"Z Mao","year":"2023","unstructured":"Mao Z, Li X, Dacosta-Urbieta A, Billard M-N, Wildenbeest J, Korsten K, et al. Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: a multi-country prospective cohort study in Europe. Vaccine. 2023;41(16):2707\u201315.","journal-title":"Vaccine."},{"issue":"11","key":"1380_CR16","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"1380_CR17","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","volume":"39","author":"P Anderson","year":"2023","unstructured":"Anderson P, Higgins V, Courcy J, Doslikova K, Davis VA, Karavali M, et al. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes. Curr Med Res Opin. 2023;39(12):1707\u201315.","journal-title":"Curr Med Res Opin."},{"issue":"8","key":"1380_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352","volume":"6","author":"SM Babineaux","year":"2016","unstructured":"Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. BMJ Open. 2016;6(8):e010352.","journal-title":"BMJ Open"},{"key":"1380_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/DMSO.S120101","volume":"9","author":"V Higgins","year":"2016","unstructured":"Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016;9:371\u201380.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"1","key":"1380_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s41687-023-00593-9","volume":"7","author":"RH Osborne","year":"2023","unstructured":"Osborne RH, Nelson LM, Fehnel S, Williams N, Bender RH, Ziemiecki R, et al. Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire\u2122 symptom scores. J Patient Rep Outcomes. 2023;7(1):51.","journal-title":"J Patient Rep Outcomes."},{"issue":"3","key":"1380_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol G","year":"1990","unstructured":"EuroQol G. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy"},{"issue":"10","key":"1380_CR22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"key":"1380_CR23","unstructured":"European Pharmaceutical Market Research Association (EphMRA). Code of Conduct 2024 [updated September 2024. Available from: https:\/\/www.ephmra.org\/sites\/default\/files\/2024-09\/2024%20EPHMRA%20Code%20of%20Conduct%20Final.pdf."},{"key":"1380_CR24","unstructured":"US Department of Health and Human Services. Summary of the HIPAA Privacy Rule 2003 [17 August 2022]. Available from: http:\/\/www.hhs.gov\/sites\/default\/files\/privacysummary.pdf."},{"issue":"20","key":"1380_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"issue":"6","key":"1380_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/irv.12729","volume":"14","author":"W Cai","year":"2020","unstructured":"Cai W, Buda S, Schuler E, Hirve S, Zhang W, Haas W. Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes. Influenza Other Respir Viruses. 2020;14(6):658\u201370.","journal-title":"Influenza Other Respir Viruses."},{"issue":"9","key":"1380_CR27","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s40121-024-01021-1","volume":"13","author":"M Haeberer","year":"2024","unstructured":"Haeberer M, Mengel M, Fan R, Toquero-Asensio M, Martin-Toribio A, Liu Q, et al. RSV risk profile in hospitalized adults and comparison with influenza and COVID-19 controls in Valladolid, Spain, 2010\u20132022. Infect Dis Ther. 2024;13(9):1983\u201399.","journal-title":"Infect Dis Ther."},{"key":"1380_CR28","volume-title":"Stata statistical software: release 18","author":"StataCorp","year":"2023","unstructured":"StataCorp. Stata statistical software: release 18. College Station, TX: StataCorp LLC; 2023."},{"issue":"12","key":"1380_CR29","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.cmi.2023.08.028","volume":"29","author":"D Bouzid","year":"2023","unstructured":"Bouzid D, Visseaux B, Ferr\u00e9 VM, Peiffer-Smadja N, Le Hingrat Q, Loubet P. Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments. Clin Microbiol Infect. 2023;29(12):1538\u201350.","journal-title":"Clin Microbiol Infect."},{"key":"1380_CR30","doi-asserted-by":"crossref","unstructured":"D'Ambrosio F, Lomazzi M, Moore M, Maida A, Ricciardi R, Munno L, et al. Addressing the underestimated burden of RSV in older adults in europe: epidemiology, surveillance gaps, and public health implications. Vaccines (Basel). 2025;13(5).","DOI":"10.3390\/vaccines13050510"},{"issue":"1","key":"1380_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/irv.12912","volume":"16","author":"Y Choi","year":"2022","unstructured":"Choi Y, Hill-Ricciuti A, Branche AR, Sieling WD, Saiman L, Walsh EE, et al. Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017\u20132019. Influenza Other Respir Viruses. 2022;16(1):151\u20138.","journal-title":"Influenza Other Respir Viruses."},{"issue":"1","key":"1380_CR32","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1080\/13696998.2023.2213125","volume":"26","author":"M Grace","year":"2023","unstructured":"Grace M, Colosia A, Wolowacz S, Panozzo C, Ghaswalla P. Economic burden of respiratory syncytial virus infection in adults: a systematic literature review. J Med Econ. 2023;26(1):742\u201359.","journal-title":"J Med Econ."},{"key":"1380_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100965","volume":"43","author":"E Phijffer","year":"2024","unstructured":"Phijffer E, Wildenbeest JG, Brouwer CNM, de Hoog M, Kneyber MCJ, Maebe S, et al. Healthcare costs related to respiratory syncytial virus in paediatric intensive care units in the Netherlands: a nationwide prospective observational study (the BRICK study). Lancet Reg Health Eur. 2024;43:100965.","journal-title":"Lancet Reg Health Eur."},{"issue":"Suppl 1","key":"1380_CR34","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1093\/infdis\/jiac069","volume":"226","author":"Z Mao","year":"2022","unstructured":"Mao Z, Li X, Korsten K, Bont L, Butler C, Wildenbeest J, et al. Economic burden and health-related quality of life of respiratory syncytial virus and influenza infection in European community-dwelling older adults. J Infect Dis. 2022;226(Suppl 1):S87-s94.","journal-title":"J Infect Dis."},{"issue":"9","key":"1380_CR35","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/pathogens13090750","volume":"13","author":"T Brosh-Nissimov","year":"2024","unstructured":"Brosh-Nissimov T, Ostrovsky D, Cahan A, Maaravi N, Leshin-Carmel D, Burrack N, et al. Adult respiratory syncytial virus infection: defining incidence, risk factors for hospitalization, and poor outcomes, a regional cohort study, 2016\u20132022. Pathogens. 2024;13(9):750.","journal-title":"Pathogens."},{"issue":"6","key":"1380_CR36","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1093\/infdis\/jiae314","volume":"230","author":"B Doty","year":"2024","unstructured":"Doty B, Ghaswalla P, Bohn RL, Stoszek SK, Panozzo CA. Incidence of RSV in adults: a comprehensive review of observational studies and critical gaps in information. J Infect Dis. 2024;230(6):e1182\u2013201.","journal-title":"J Infect Dis."},{"key":"1380_CR37","doi-asserted-by":"publisher","first-page":"1385439","DOI":"10.3389\/fmicb.2024.1385439","volume":"15","author":"A Malik","year":"2024","unstructured":"Malik A, Szpunar S, Sharma M, Johnson LB, Saravolatz L, Bhargava A. Predictors of prolonged length of stay in adult patients with respiratory syncytial virus infections\u2014a multi-center historical cohort study. Front Microbiol. 2024;15:1385439.","journal-title":"Front Microbiol."},{"issue":"9","key":"1380_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70008","volume":"18","author":"R Osei-Yeboah","year":"2024","unstructured":"Osei-Yeboah R, Amankwah S, Begier E, Adedze M, Nyanzu F, Appiah P, et al. Burden of respiratory syncytial virus (RSV) infection among adults in nursing and care homes: a systematic review. Influenza Other Respir Viruses. 2024;18(9):e70008.","journal-title":"Influenza Other Respir Viruses."},{"issue":"Supplement_1","key":"1380_CR39","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1093\/infdis\/jiad510","volume":"229","author":"R Osei-Yeboah","year":"2024","unstructured":"Osei-Yeboah R, Johannesen CK, Egeskov-Cavling AM, Chen J, Lehtonen T, Fornes AU, et al. Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study. J Infect Dis. 2024;229(Supplement_1):S70\u20137.","journal-title":"J Infect Dis"},{"issue":"5","key":"1380_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad203","volume":"10","author":"JK DeMartino","year":"2023","unstructured":"DeMartino JK, Lafeuille MH, Emond B, Rossi C, Wang J, Liu S, et al. Respiratory syncytial virus-related complications and healthcare costs among a Medicare-insured population in the United States. Open Forum Infectious Diseases. 2023;10(5):ofad203.","journal-title":"Open Forum Infectious Diseases"},{"issue":"12","key":"1380_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.47618","volume":"8","author":"A Hviid","year":"2025","unstructured":"Hviid A, Fischer TK, Biering-S\u00f8rensen T, Bech Svalgaard I. Cardiovascular events 1 year after respiratory syncytial virus infection in adults. JAMA Netw Open. 2025;8(12):e2547618-e.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1380_CR42","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10198-019-01054-1","volume":"20","author":"T Grochtdreis","year":"2019","unstructured":"Grochtdreis T, Dams J, K\u00f6nig H-H, Konnopka A. Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set. Eur J Health Econ. 2019;20(6):933\u201344.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"1380_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pharp.2025.03.001","volume":"1","author":"Z Wang","year":"2025","unstructured":"Wang Z, Luo N, Wang P. A comparative analysis of EQ-5D-5L general population norms across 23 countries: gender and age disparities. Pharmacoecon Policy. 2025;1(1):5\u201314.","journal-title":"Pharmacoecon Policy"},{"issue":"10","key":"1380_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70174","volume":"19","author":"SF Hak","year":"2025","unstructured":"Hak SF, Wildenbeest JG, Bracaloni S, Scarpaci M, Cosci T, Esposito E, et al. Clinical and socioeconomic burden of RSV infections among older adults in primary care: an international prospective cohort study. Influenza Other Respir Viruses. 2025;19(10):e70174.","journal-title":"Influenza Other Respir Viruses"},{"issue":"6","key":"1380_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11806","volume":"4","author":"E Bosco","year":"2021","unstructured":"Bosco E, van Aalst R, McConeghy KW, Silva J, Moyo P, Eliot MN, et al. Estimated cardiorespiratory hospitalizations attributable to influenza and respiratory syncytial virus among long-term care facility residents. JAMA Netw Open. 2021;4(6):e2111806.","journal-title":"JAMA Netw Open."},{"issue":"17","key":"1380_CR46","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa043951","volume":"352","author":"AR Falsey","year":"2005","unstructured":"Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749\u201359.","journal-title":"N Engl J Med"},{"key":"1380_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122092","author":"S Maggi","year":"2022","unstructured":"Maggi S, Veronese N, Burgio M, Cammarata G, Ciuppa ME, Ciriminna S, et al. Rate of hospitalizations and mortality of respiratory syncytial virus infection compared to influenza in older people: a systematic review and meta-analysis. Vaccines (Basel). 2022. https:\/\/doi.org\/10.3390\/vaccines10122092.","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"1380_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106570","volume":"91","author":"R Symes","year":"2025","unstructured":"Symes R, Keddie SH, Walker J, McKeever T, Ahmad S, Arnold D, et al. Burden of respiratory syncytial virus infection in older adults hospitalised in England during 2023\/24. J Infect. 2025;91(3):106570.","journal-title":"J Infect."},{"issue":"2","key":"1380_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/cid\/ciy991","volume":"69","author":"B Ackerson","year":"2019","unstructured":"Ackerson B, Tseng HF, Sy LS, Solano Z, Slezak J, Luo Y, et al. Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69(2):197\u2013203.","journal-title":"Clin Infect Dis."},{"issue":"5","key":"1380_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13275","volume":"18","author":"AR Falsey","year":"2024","unstructured":"Falsey AR, Walsh EE, House SL, Vandendijck Y, Stevens M, Chan EKH, et al. Assessment of illness severity in adults hospitalized with acute respiratory tract infection due to influenza, respiratory syncytial virus, or human metapneumovirus. Influenza Other Respir Viruses. 2024;18(5):e13275.","journal-title":"Influenza Other Respir Viruses"},{"issue":"10462","key":"1380_CR51","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(24)02150-0","volume":"404","author":"AR Branche","year":"2024","unstructured":"Branche AR. Real-world effectiveness studies of the benefit of RSV vaccines. Lancet. 2024;404(10462):1498\u2013500.","journal-title":"Lancet"},{"issue":"2","key":"1380_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/QCO.0000000000001000","volume":"37","author":"S Kenmoe","year":"2024","unstructured":"Kenmoe S, Nair H. The disease burden of respiratory syncytial virus in older adults. Curr Opin Infect Dis. 2024;37(2):129\u201336.","journal-title":"Curr Opin Infect Dis"},{"issue":"10485","key":"1380_CR53","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0140-6736(25)00346-0","volume":"405","author":"AA Mensah","year":"2025","unstructured":"Mensah AA, Whitaker H, Andrews NJ, Watson CH. Early impact of RSV vaccination in older adults in England. Lancet. 2025;405(10485):1139\u201340.","journal-title":"Lancet"},{"issue":"1","key":"1380_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2514357","volume":"21","author":"MD Tanriover","year":"2025","unstructured":"Tanriover MD, Azap A, Cakir Edis E, Ozger HS, Pullukcu H, Sonmezer MC, et al. Respiratory syncytial virus (RSV) infections in adults: current trends and recommendations for prevention - a global challenge from a local perspective. Hum Vaccin Immunother. 2025;21(1):2514357.","journal-title":"Hum Vaccin Immunother"},{"issue":"16","key":"1380_CR55","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","volume":"388","author":"EE Walsh","year":"2023","unstructured":"Walsh EE, P\u00e9rez Marc G, Zareba AM, Falsey AR, Jiang Q, Patton M, et al. Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. N Engl J Med. 2023;388(16):1465\u201377.","journal-title":"N Engl J Med"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01380-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01380-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01380-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T18:02:22Z","timestamp":1783620142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01380-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1380"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01380-x","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"James Lucas, Emily Quinones, Mayesha Chowdhury, Libby Turner and James Piercy are employees of Adelphi Real World (Bollington, UK), which received funding from Pfizer in connection with the development of the study, including medical writing and editorial assistance. Diana Mendes, St\u00e9phane Fi\u00e9vez, Caroline Lade, Roberto Di Virgilio, Alejandra L\u00f3pez-Ib\u00e1\u00f1ez de Aldecoa and Reiko Sato are employees of Pfizer and may hold stocks and shares options.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Patients provided informed consent to take part in the survey and for use of their anonymized and aggregated data for research and publication in scientific journals. No identifiable protected health information were collected; all data were anonymized and aggregated prior to analysis. Data collection was undertaken in accordance with European Pharmaceutical Marketing Research Association guidelines, and as such did not require ethics committee approval. The survey materials were submitted to the PEARL Institutional Review Board (IRB study number: 2023-0459). Following a review, a waiver was granted deeming the survey to be exempt from ethical approval. In addition, each survey was performed in full accordance with relevant legislation at the time of data collection, including the US Health Insurance Portability and Accountability Act 1996 and the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}